These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20878998)

  • 41. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.
    Liu HT; Kuo HC
    Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overactive bladder is not only overactive but also hypersensitive.
    Lee SR; Kim HJ; Kim A; Kim JH
    Urology; 2010 May; 75(5):1053-9. PubMed ID: 20092879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
    Herschorn S; Swift S; Guan Z; Carlsson M; Morrow JD; Brodsky M; Gong J
    BJU Int; 2010 Jan; 105(1):58-66. PubMed ID: 20132103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.
    Cheng Y; Mansfield KJ; Allen W; Millard RJ; Burcher E; Moore KH
    Neurourol Urodyn; 2013 Sep; 32(7):969-73. PubMed ID: 23129360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bladder diary measurements in asymptomatic females: functional bladder capacity, frequency, and 24-hr volume.
    Amundsen CL; Parsons M; Tissot B; Cardozo L; Diokno A; Coats AC
    Neurourol Urodyn; 2007; 26(3):341-9. PubMed ID: 17315222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bladder diary patterns in detrusor overactivity and urodynamic stress incontinence.
    Parsons M; Amundsen CL; Cardozo L; Vella M; Webster GD; Coats AC;
    Neurourol Urodyn; 2007; 26(6):800-6. PubMed ID: 17335054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comment on "Rectal distension: the effect on bladder function".
    De Wachter S
    Neurourol Urodyn; 2011 Mar; 30(3):353. PubMed ID: 20886572
    [No Abstract]   [Full Text] [Related]  

  • 49. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.
    Apostolidis A; Gonzales GE; Fowler CJ
    Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity.
    Nitti VW; Rovner ES; Bavendam T
    BJU Int; 2010 May; 105(9):1268-75. PubMed ID: 19889062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Women overestimate daytime urinary frequency: the importance of the bladder diary.
    Stav K; Dwyer PL; Rosamilia A
    J Urol; 2009 May; 181(5):2176-80. PubMed ID: 19296975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overactive bladder symptoms: do we need urodynamics?
    Digesu GA; Khullar V; Cardozo L; Salvatore S
    Neurourol Urodyn; 2003; 22(2):105-8. PubMed ID: 12579626
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and correlation of urinary incontinence and overactive bladder in Taiwanese women.
    Chen GD; Lin TL; Hu SW; Chen YC; Lin LY
    Neurourol Urodyn; 2003; 22(2):109-17. PubMed ID: 12579627
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanism of bladder dysfunction in idiopathic normal pressure hydrocephalus.
    Sakakibara R; Kanda T; Sekido T; Uchiyama T; Awa Y; Ito T; Liu Z; Yamamoto T; Yamanishi T; Yuasa T; Shirai K; Hattori T
    Neurourol Urodyn; 2008; 27(6):507-10. PubMed ID: 18092331
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is low bladder compliance predictive of detrusor overactivity?
    Harding C; Dorkin TJ; Thorpe AC
    Neurourol Urodyn; 2009; 28(1):74-7. PubMed ID: 18726946
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuromodulative treatment with percutaneous tibial nerve stimulation for intractable detrusor instability: outcomes following a shortened 6-week protocol.
    Yoong W; Ridout AE; Damodaram M; Dadswell R
    BJU Int; 2010 Dec; 106(11):1673-6. PubMed ID: 20590544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lower urinary tract dysfunction in type 1 familial amyloidotic polyneuropathy in Kumamoto, Japan.
    Wada Y; Ando Y; Kai N; Takahashi W; Kikukawa H; Nakanishi J; Honda J; Jinnouchi Y; Ueda S
    Int J Urol; 2006 Dec; 13(12):1475-8. PubMed ID: 17118020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire.
    Haab F; Richard F; Amarenco G; Coloby P; Arnould B; Benmedjahed K; Guillemin I; Grise P
    Urology; 2008 Apr; 71(4):646-56. PubMed ID: 18313122
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urethral dilatation: Is there any benefit over cystoscopy and distension? A randomized trial in women with overactive bladder symptoms.
    Basu M; Khullar V; Duckett J
    Neurourol Urodyn; 2014 Mar; 33(3):283-8. PubMed ID: 23636866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.